New immunotherapy drug doubles remission time for head and neck cancer patients
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN

Play all audios:

Newsletters ePaper Sign in HomeIndiaKarnatakaOpinionWorldBusinessSportsVideoEntertainmentDH SpecialsOperation SindoorNews ShotsExplainersBengaluruTrendingPhotosDH BrandspotHomeNews
ShotsTrendingMenuĂ—ADVERTISEMENT ADVERTISEMENT ADVERTISEMENTHomehealthNew immunotherapy drug doubles remission time for head and neck cancer patientsIn a trial involving more than 700
patients across 24 countries, those who received the drug followed by standard care which includes surgery and radiotherapy, stayed in remission for an average of five years, compared to 30
months for those on standard care alone.DH Web DeskLast Updated : 31 May 2025, 10:19 IST Follow Us :
CommentsADVERTISEMENTPublished 31 May 2025, 10:19 ISTCancerHealth newsCancer treatmentFollow us on : Follow Us IndiaSouthNorthWestEast & North EastOperation SindoorOpinionEditorialSpeak
OutCartoonKarnatakaBengaluruSportsCricketIPL 2025FootballEntertainmentMovie ReviewsPhotosTechnologyWorldSpecialsDH on SundayDH on SaturdaySign up for NewslettersAll NewslettersTop News of
the DayPolitical TheatreDH SportsletterExplainersExplained | From bros to foes: How the unlikely Trump-Musk relationship implodedThree major lapses: No coordination, no communication, no
crowd managementExplained | Trump's new travel ban: Who is exemptExplained | What we know about the attack against Jewish demonstrators in ColoradoWhat's BrewingRajasthan's total fertility
rate falls below replacement rate to 2.0Airlines to cancel 114 daily flights for 3 months due to Delhi airport runway upgradation workDelhi: Satyendar Jain appears before ACB for questioning
in classroom construction casePolitical row brews over Bakrid holiday in KeralaLatest News444 active cases of Covid in Karnataka, total since Jan 1 rises to 837Indian Navy set to induct new
anti-submarine ships as Pak strengthens underwater fleetACB quizzes Satyendar Jain for over 5 hours in graft case, he calls it 'politically motivated'Chinnaswamy stampede: 2 more FIRs
against RCB, KSCA; complaint lodged against star batter Virat KohliThe Printers Mysore LtdPrajavaniSudhaMayuraEpaperClassifiedsContactAboutPrivacy PolicyTermsDisclaimerGrievance Redressal